000			01568 a2200469 4500
005			20250513225040.0
264		0	_c20010208
008			200102s 0 0 eng d
022			_a1357-0560
024	7		_a10.1007/BF02782196 _2doi
040			_aNLM _beng _cNLM
100	1		_aPantic, M
245	0	0	_aAdditional chromosome aberrations in acute promyelocytic leukemia: characteristics and prognostic influence. _h[electronic resource]
260			_bMedical oncology (Northwood, London, England) _cNov 2000
300			_a307-13 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aChromosomes, Human, Pair 15 _xgenetics
650	0	4	_aChromosomes, Human, Pair 17 _xgenetics
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aKaryotyping
650	0	4	_aLeukemia, Promyelocytic, Acute _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aSurvival Analysis
650	0	4	_aTranslocation, Genetic
650	0	4	_aTretinoin _xtherapeutic use
700	1		_aNovak, A
700	1		_aMarisavljevic, D
700	1		_aDjordjevic, V
700	1		_aElezovic, I
700	1		_aVidovic, A
700	1		_aColovic, M
773	0		_tMedical oncology (Northwood, London, England) _gvol. 17 _gno. 4 _gp. 307-13
856	4	0	_uhttps://doi.org/10.1007/BF02782196 _zAvailable from publisher's website
999			_c11055907 _d11055907